N/A
N=11
Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia
Ventricular Tachycardia
Bottom Line
View on ClinicalTrials.gov: NCT02419547 ↗Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Number of Participants Who Had Inducible Ventricular Tachycardia Under General Anesthesia. — 7; 5; 5 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Versed (Drug); Fentanyl (Drug); Propofol (Drug); Sevoflurane (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Brigham and Women's Hospital
- Primary completion
- Apr 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Had Inducible Ventricular Tachycardia Under General Anesthesia. |
7; 5; 5 | — |
Summary
This research study is being done to see whether general anesthesia (GA) affects our ability to start ventricular tachycardia (VT) during an VT ablation procedure.
Data collected during this research study will help electrophysiologists and anesthesiologists to make the best decisions about the best anesthetic conditions to use to perform VT ablations.
This research study is a "pilot" study. Pilot studies are done on a small group of subjects to learn if a larger study would be useful.
Eligibility Criteria
Inclusion Criteria
- Patients with VT and have an implanted ICD who are scheduled for VT catheter ablation.
- Patients 18 years of age or older
Exclusion Criteria
- Patients with difficult airway management or patients with contra/ relative contra indication for general anesthesia or known allergies to any of the proposed anesthetic agents
- Women who are pregnant
Data sourced from ClinicalTrials.gov (NCT02419547). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.